The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Immunology
(Aug 2022)
Restricting use of adenovirus vector-based COVID vaccines could endanger public and global health
Hildegund C. J. Ertl,
Sue L. Currie,
Andrew D. Luber
Affiliations
Hildegund C. J. Ertl
The Wistar Institute, Philadelphia, PA, United States
Sue L. Currie
Virion Therapeutics, LLC, Newark, DE, United States
Andrew D. Luber
Virion Therapeutics, LLC, Newark, DE, United States
DOI
https://doi.org/10.3389/fimmu.2022.985382
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
VITT
COVID
adenoviral (Ad) vector
vaccines
global public health
thrombosis with thrombocytopenia syndrome (TTS)
WeChat QR code
Close
